Vaccination
We provide vaccination services including and not limited to Comirnaty bivalent vaccine, Gardasil9 and Zostavax.
Gardisil 9
Gardasil 9 was officially launched in April 2016 offering an enhanced version of the vaccine to protect against 9 strains of HPV.
The new Gardasil 9 covers the following HPV types, 6, 11, 16, 18, 31, 33, 45, 52 and 58.
These 9 HPV types also cause premalignant lesions and cancers affecting the cervix, vulva and anus, and genital warts (Condyloma acuminata).
Gardasil 9 has the potential to prevent approximately 80-90% of cervical, vulvar, vaginal and anal cancers while Gardasil 4 has 50-75%.
The new Gardasil 9 covers the following HPV types, 6, 11, 16, 18, 31, 33, 45, 52 and 58.
These 9 HPV types also cause premalignant lesions and cancers affecting the cervix, vulva and anus, and genital warts (Condyloma acuminata).
Gardasil 9 has the potential to prevent approximately 80-90% of cervical, vulvar, vaginal and anal cancers while Gardasil 4 has 50-75%.
Shingrix
Shingrix is indicated for prevention of herpes zoster (HZ) and post-herpetic neuralgia (PHN), in adults 50 years of age or older . The primary vaccination schedule consists of two doses of 0.5 ml each: an initial dose followed by a second dose 2 months later. If flexibility in the vaccination schedule is necessary, the second dose can be administered between 2 and 6 months after the first dose . Shingrix can be given with the same schedule in individuals previously vaccinated with live attenuated HZ vaccine .
